Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMillennium & Copthorne Hotels Share News (MLC)

  • There is currently no data for MLC

Thursday broker round-up

Thu, 28th Jun 2012 10:24
3i Group: Citigroup upgrades to buy, target lifted from 215p to 220p.Abcam: Investec upgrades to buy, target lifted from 349p to 466p; Peel Hunt raises target from 440p to 480p, buy rating unchanged.bwin.party: UBS cuts target from 165p to 125p, neutral rating unchanged.Cookson: UBS cuts target from 675p to 200p, neutral rating kept.Debenhams: Peel Hunt keeps buy rating and 95p target.Diageo: RBS Capital Markets initiates coverage with outperform rating and 1,900p target.DS Smith: Investec cuts target from 190p to 170p, buy rating kept.Greene King: Peel Hunt keeps buy rating and 617p target.Hargreaves Lansdown: Peel Hunt keeps hold rating and 450p target.IMI: UBS cuts target from 950p to 850p, neutral rating kept.Ladbrokes: Peel Hunt downgrades from buy to hold, target left at 180p.Lloyds: Investec maintains buy rating and 40p target.Millennium & Copthorne : Morgan Stanley upgrades to overweight, target lifted from 540p to 630p.Morgan Sindall: Liberum Capital downgrades to hold.Northgate: UBS raises target from 230p to 245p, buy recommendation unchanged.Polymetal: UBS downgrades from buy to neutral, target cut from 1,060p to 970p.Reckitt Benckiser: RBS Capital Markets initiates coverage with underperform rating and 3,200p target; Credit Suisse downgrades to neutral, target cut from 3,800p to 3,500p.SABMiller: RBS Capital Markets initiates coverage with sector performer rating and 2,800p target.Spectris: UBS cuts target from 1,900p to 1,650p, buy rating unchanged. Spirax-Sarco: UBS cuts target from 2,100p to 2,000p, neutral rating kept.Standard Chartered: UBS cuts target from 1,800p to 1,750p, buy rating kept; HB Markets downgrades to hold.Tesco: Numis puts buy rating under review.Yule Catto: UBS cuts target from 260p to 177p, buy rating kept; Peel Hunt cuts target from 260p to 185p, buy rating unchanged; HB Markets downgrades to sell; Deutsche Bank downgrades to hold.BC

Related News

LONDON MARKET CLOSE: Miners peg back FTSE 100 while mid-caps struggle
7 hours ago

LONDON MARKET CLOSE: Miners peg back FTSE 100 while mid-caps struggle

(Alliance News) - The FTSE 100 edged lower on Tuesday held back by weak miners, while fresh US tech falls and soft UK economic data added to the muted...

Singapore Airlines launches $221 million dim sum bond at 2.38% yield
8 hours ago

Singapore Airlines launches $221 million dim sum bond at 2.38% yield

SINGAPORE, ​June 23 (Reuters) - Singapore Airlines, or SIA, launched a 1.5 billion ​yuan ($221.1 ‌million) five-year dim sum bond on Tuesday with a ⁠y...

Grocery sales shine as heatwave boosts demand - NIQ
13 hours ago

Grocery sales shine as heatwave boosts demand - NIQ

(Sharecast News) - Grocery sales shone in late May, industry data showed on Tuesday, boosted by warmer weather and the start of a summer of major spor...

Millennium & Copthorne Hotels News

EARNINGS AND TRADING: Connecting Excellence hails record January fees
26 Feb 2026

EARNINGS AND TRADING: Connecting Excellence hails record January fees

(Alliance News) - The following is a round-up of earnings and trading updates for London-listed companies, issued on Thursday and not separately repor...

Malin in valuation fall amid Poseida sale, EUR150 million return
27 Aug 2025

Malin in valuation fall amid Poseida sale, EUR150 million return

(Alliance News) - Malin Corp PLC on Wednesday reported a valuation decline over the first half of 2025, but hailed the sale of its Poseida Therapeutic...

IN BRIEF: Malin completes oversubscribed EUR150 million tender offer
21 Mar 2025

IN BRIEF: Malin completes oversubscribed EUR150 million tender offer

Malin Corp PLC - Dublin-based investor in life sciences companies - Announces results of tender offer, which closed on Thursday. Says the offer was ov...

Roche to close USD1.5 billion acquisition of biopharma firm Poseida
8 Jan 2025

Roche to close USD1.5 billion acquisition of biopharma firm Poseida

(Alliance News) - Roche Holding AG on Wednesday said that it has completed the tender offer for all outstanding shares of Poseida Therapeutics Inc, a ...

IN BRIEF: Malin intrinsic equity value falls in half-year
27 Aug 2024

IN BRIEF: Malin intrinsic equity value falls in half-year

Malin Corp PLC - Dublin-based investor in life sciences companies - Reports intrinsic equity value of EUR6.44 at June 30 half-year end, down 1.8% from...